Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.
2.

Smallpox and live-virus vaccination in transplant recipients.

Fishman JA.

Am J Transplant. 2003 Jul;3(7):786-93. Review.

3.

Smallpox: a review of clinical disease and vaccination.

Lofquist JM, Weimert NA, Hayney MS.

Am J Health Syst Pharm. 2003 Apr 15;60(8):749-56; quiz 757-8. Review.

PMID:
12749161
4.

Ring vaccination versus mass vaccination in event of a smallpox attack.

Lau CY, Wahl B, Foo WK.

Hawaii Med J. 2005 Feb;64(2):34-6, 53. Review.

PMID:
15871566
5.

Pathogenesis and potential antiviral therapy of complications of smallpox vaccination.

Bray M.

Antiviral Res. 2003 Apr;58(2):101-14. Review.

PMID:
12742570
6.

Bioterrorism preparedness--Part II. Smallpox vaccination in a hospital setting.

Jacobs LM, Emanuelsen K, McKay C, Burns K.

Conn Med. 2004 Jan;68(1):27-35. Review.

PMID:
14752914
7.

Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?

Napolitano PG, Ryan MA, Grabenstein JD.

Am J Obstet Gynecol. 2004 Dec;191(6):1863-7. Review.

PMID:
15592266
8.

The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.

Handley L, Buller RM, Frey SE, Bellone C, Parker S.

Expert Rev Vaccines. 2009 Jul;8(7):841-50. doi: 10.1586/erv.09.55. Review.

PMID:
19538111
9.

Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968.

Aragón TJ, Ulrich S, Fernyak S, Rutherford GW.

BMC Public Health. 2003 Aug 11;3:26. Review.

10.

Smallpox and pregnancy: from eradicated disease to bioterrorist threat.

Suarez VR, Hankins GD.

Obstet Gynecol. 2002 Jul;100(1):87-93. Review.

PMID:
12100808
11.

Smallpox vaccines for biodefense: need and feasibility.

Artenstein AW, Grabenstein JD.

Expert Rev Vaccines. 2008 Oct;7(8):1225-37. doi: 10.1586/14760584.7.8.1225. Review.

PMID:
18844596
12.

Smallpox vaccination and bioterrorism with pox viruses.

Mayr A.

Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):423-30. Review.

PMID:
12818626
13.

Smallpox: clinical highlights and considerations for vaccination.

Mahoney MC, Symons AB, Kimmel SR.

J Postgrad Med. 2003 Apr-Jun;49(2):141-7. Review.

14.

ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine.

Greenberg RN, Kennedy JS.

Expert Opin Investig Drugs. 2008 Apr;17(4):555-64. doi: 10.1517/13543784.17.4.555 . Review.

PMID:
18363519
15.
16.

Smallpox, bioterrorism, and the neurologist.

Cleri DJ, Villota FJ, Porwancher RB.

Arch Neurol. 2003 Apr;60(4):489-94. Review. No abstract available.

PMID:
12707060
17.

ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.

Monath TP, Caldwell JR, Mundt W, Fusco J, Johnson CS, Buller M, Liu J, Gardner B, Downing G, Blum PS, Kemp T, Nichols R, Weltzin R.

Int J Infect Dis. 2004 Oct;8 Suppl 2:S31-44. Review.

18.

Oncology nursing implications related to smallpox bioterrorism preparations.

Mack K.

Clin J Oncol Nurs. 2004 Feb;8(1):51-5. Review.

PMID:
14983764
19.

Preventing second-generation infections in a smallpox bioterror attack.

Kaplan EH.

Epidemiology. 2004 May;15(3):264-70. Review.

PMID:
15097005
20.

[Methods and Means for Defense from Collateral Action of Vaccine Virus after Vaccination Against Spallpox].

Chernikova NK, Bondareva TA, Borisevich SV, Podkujko VN, Khmelyev AL, Dorokhina TV.

Antibiot Khimioter. 2015;60(9-10):46-50. Review. Russian.

PMID:
27141639

Supplemental Content

Support Center